The prize recognizes a scientist of international renown who has made a major scientific discovery
in basic cancer research or who has made significant contributions to translational cancer research.
When Amgen, a biotech firm, tried to replicate 53 «landmark» studies
in basic cancer research in 2012, it could confirm only six of them.
Not exact matches
In addition to increasing the basic understanding of how the various arms of the immune system reach their sites of differentiation and activity, these findings may aid in cancer researc
In addition to increasing the
basic understanding of how the various arms of the immune system reach their sites of differentiation and activity, these findings may aid
in cancer researc
in cancer research.
Delegates included those interested
in all aspects of lung
cancer, including surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists,
basic research scientists, with special sessions for nurses, allied health professionals and advocacy members.
The lack of answers to these most
basic of
research questions has led to, at best, a stalemate
in the war on
cancer, which kills more than a half million U.S. patients annually.
The trial also recorded fewer cases of lung
cancer in those on the treatment, consistent with
basic research findings hinting that the same inflammatory pathway may initiate or spur tumor growth.
«This
basic study will allow more defined
research into the genomic variations associated with colon
cancer that are
in the region where BMP is regulated.»
Focusing on
basic research for the functional regulation of innate and adaptive immunity and on translational
research for
cancer immunotherapies, the National Key Laboratory of Medical Immunology has been conducting innovative
research and exploration, and is becoming a rising star
in the international immunology community.
So how are these huge shifts
in the
research firmament — multidisciplinarity, translational research, and commercialization — affecting one of the largest funders of basic biomedical science in the country, Cancer Rese
research firmament — multidisciplinarity, translational
research, and commercialization — affecting one of the largest funders of basic biomedical science in the country, Cancer Rese
research, and commercialization — affecting one of the largest funders of
basic biomedical science
in the country,
Cancer ResearchResearch UK?
Called the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) and funded by the drug giant Novartis, the trial also found fewer cases of lung
cancer in those on the treatment, rekindling
basic research findings hinting that the same inflammatory pathway may initiate or spur the growth of such tumors.
«We are looking to optimize the combinations of targeted therapies and the scheduling of those therapies so we can improve tumor shrinkage and minimize potential toxicities for a patient,» said Andrew Aplin, PhD, Associate Director for
Basic Research and the Program Leader for
Cancer Cell Biology and Signaling (CCBS)
in the NCI - designated Sidney Kimmel
Cancer Center at Jefferson Health.
Swiss Bridge Award for
Research in Cancer Funding for basic cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 5
Research in Cancer Funding for basic cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 500
Cancer Funding for
basic cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 500
cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 5
research, genetics and epidemiology, psycho - oncology and prevention
research (total support approximating CHF 5
research (total support approximating CHF 500,000).
The
research, published
in the Journal of
Cancer Survivorship, also adds to the
basic understanding of the pathophysiology of traumatic stress
in general and the underlying mechanisms involved with resolving it.
Many young scientists at the
basic research end of the spectrum will admit that they were initially attracted more by the desire to investigate fundamental questions
in biology than to work specifically on
cancer.
This question was answered
in research published
in the current online edition of Molecular Cell, by senior author Eileen White, PhD, associate director for
basic science at the
Cancer Institute of New Jersey, and colleagues.
«
Research into
basic workings of immune system points to way of improving therapies for
cancer: Differences
in wiring of «exhausted» and effective T cells indicate possible gene - editing targets.»
Understanding the physiological mechanisms that cause or, as
in this case, prevent genetic instability is a
basic question
in Molecular Biology and Biomedicine which is of vital importance
in the
research against
cancer, given that genetic instability is a distinctive feature of tumorous cells.
Researchers at the Institute for
Basic Science (IBS)
in South Korea have succeeded
in developing the world's first technology to control specific protein functions
in living cells by using lights, which may be useful
in future
cancer cell
research.
Research fields are diverse, including basic research on cell proliferation, analysis of tumour cells and tissues to detect gene mutations, and identification of potential therapeutic targets in
Research fields are diverse, including
basic research on cell proliferation, analysis of tumour cells and tissues to detect gene mutations, and identification of potential therapeutic targets in
research on cell proliferation, analysis of tumour cells and tissues to detect gene mutations, and identification of potential therapeutic targets
in cancer.
This advance
in breast
cancer research reflects the mission of Stem Cell Reports to provide an open - access forum that communicates
basic discoveries
in stem cell
research as well as translational and clinical studies.
In its twenty years of operation, the NRSA program has made it possible for many thousands of talented individuals in the basic biomedical, behavioral, and clinical sciences to sharpen their research skills and to apply those skills to topics of special concern to the nation, such as aging, hypertension, the genetic basis of disease, acquired immune deficiency syndrome (AIDS), cancer, environmental toxicology, nutrition and health, and substance abus
In its twenty years of operation, the NRSA program has made it possible for many thousands of talented individuals
in the basic biomedical, behavioral, and clinical sciences to sharpen their research skills and to apply those skills to topics of special concern to the nation, such as aging, hypertension, the genetic basis of disease, acquired immune deficiency syndrome (AIDS), cancer, environmental toxicology, nutrition and health, and substance abus
in the
basic biomedical, behavioral, and clinical sciences to sharpen their
research skills and to apply those skills to topics of special concern to the nation, such as aging, hypertension, the genetic basis of disease, acquired immune deficiency syndrome (AIDS),
cancer, environmental toxicology, nutrition and health, and substance abuse.
The aim of the Interdisciplinary Training
in Cancer Research training program is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sci
Cancer Research training program is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social s
Research training program is to train young scientists to design and conduct
research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social s
research on significant problems
in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sci
cancer by combining information and approaches from different scientific disciplines, including
basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sciences.
The Visikol technology has applications
in the fields of toxicology, pre ‐ clinical drug development, clinical diagnostics,
basic research and plant biology and can be particularly valuable
in fields like drug development and
cancer diagnostics.
Many of these novel
cancer immunotherapy approaches, which originated from
basic science
research in CCIR laboratories, are now being explored as new treatment modalities
in patients, with a significant number advancing through clinical trials towards FDA approval.
Likewise,
research specifically related to endometrial
cancer is not well - represented
in the
basic sciences.
The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative
basic science
in tumor immunology, enables experts to advance their most ambitious clinical and translational
research ideas to cure
cancer, and accelerates studies that one group or company could not do alone.
The program supports
basic, pre-clinical, and translational
research that can be directly applied to optimizing
cancer immunotherapy
in the clinic.
Wistar is expanding its
research efforts on brain
cancer, both
in basic and translational
research.
Findings from
basic research, such as studies of
cancer cells
in the laboratory, can ultimately define
research questions to study
in humans, such as helping to identify drugs to test
in clinical trials.
In order to obtain the comprehensive designation, which is the highest ranking the National Cancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and contro
In order to obtain the comprehensive designation, which is the highest ranking the National
Cancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and co
Cancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of
basic laboratory
research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and contro
in several fields, the ability to translate those
research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to
cancer prevention and co
cancer prevention and control.
The grant will support
basic, pre-clinical, and translational
research, which will provide information that can be directly applied to optimizing
cancer immunotherapy
in the clinic.
Our researchers
in the Center for Childhood
Cancer are conducting basic science, translational and clinical research geared toward finding a cure for childhood cancer and improving the toxicity of current treat
Cancer are conducting
basic science, translational and clinical
research geared toward finding a cure for childhood
cancer and improving the toxicity of current treat
cancer and improving the toxicity of current treatments.
«It was extremely exciting to get this award as it will provide my lab both the resources and the stability for our ongoing efforts,» says Shaw, who is also the director of the Salk
Cancer Center, which is one of just seven NCI - designated
Basic Research Cancer Centers
in the country.
LA JOLLA — The Salk Institute, which hosts a National
Cancer Institute (NCI)-- designated cancer center and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in c
Cancer Institute (NCI)-- designated
cancer center and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in c
cancer center and Indivumed GmbH, a world leading
cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in c
cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human
cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in c
cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge
basic and translational
research in cancercancer.
In 1999, Ashworth was appointed the first director of the ICR's Breakthrough Breast
Cancer Research Centre, which is now internationally recognized, with more than 120 scientists and researchers working on aspects of the disease ranging from basic molecular and cellular biology through to translational research and clinical
Research Centre, which is now internationally recognized, with more than 120 scientists and researchers working on aspects of the disease ranging from
basic molecular and cellular biology through to translational
research and clinical
research and clinical trials.
To take a finding
in basic research, such as identifying a mutant protein that drives a particular
cancer, and develop a drug that inactivates the protein and performs well
in cells
in the lab and
in animal models can take years, if not decades.
Klemke, Wang, and their colleagues are involved
in research on aspects of the
basic biology behind metastasis — trying to identify the signal transduction mechanisms that lead to the spread of breast
cancer cells.
This kicks off the joint Genomic Medicine Institute &
Cancer Biology fundraising initiative to support
basic and translational
research in the two departments.
«Under her leadership, the Ben May Department has played a key role
in basic biological
research as well as
in bridging
basic cancer biology and translational
research.
Other Institutions also belong to the Campus: the University of Milan; Cogentech, an IFOM - IEO consortium committed to developing leading genomic technologies (nanotechnologies, proteomics, bioinformatics, disease models), the European School of Molecular Medicine (SEMM), that organizes training
in emerging sectors of Biomedicine, offering the first European PhDs
in Molecular Medicine, Medical Nanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech company whose mission is to develop new therapies against
cancer and aging - related disease; Biopolo, a not for profit company involved
in the technological transfer of
basic research to the productive system.
Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging
basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses
in cancer and their potential therapeutic manipulation.
From the development of insulin and transplant surgery to modern day advances, including gene therapies and
cancer treatments; animals — from mice to monkeys — continue to play a crucial role
in both
basic and applied
research.
The ITCMS program,
in its 41st year, was established to provide postdoctoral fellows an interdisciplinary training experience, including
basic and translational
research opportunities with renowned investigators, and an extensive scope of workshops and training modules with an emphasis on
cancer model systems.
Nobel Laureate
in Physiology or Medicine Full Member,
Basic Sciences Division Fred Hutchinson
Cancer Research Center Affiliate Professor of Physiology and Biophysics University of Washington, Seattle Investigator, Howard Hughes Medical Institute
June 2013 — Byron Lee, MD, PhD, who completed his
research year as part of the Urology residency program in the Genomic Medicine Institute under the mentorship of Angela Ting, PhD, won a second place Lower Memorial Award in basic science for a paper published in Cancer R
research year as part of the Urology residency program
in the Genomic Medicine Institute under the mentorship of Angela Ting, PhD, won a second place Lower Memorial Award
in basic science for a paper published
in Cancer ResearchResearch.
To identify and stimulate meritorious and fundable
basic science - based and translational / clinical
research in breast
cancer
The benefits of primate
research include advances
in understanding of
cancer, infectious diseases, metabolic disorders, spinal cord injuries, substance abuse, and other
basic biological and behavioral processes.
Through
basic and clinical biomedical
research and training, NCI conducts and supports
research that will lead to a future
in which we can prevent
cancer before it starts, identify
cancers that do develop at the earliest stage, eliminate
cancers through innovative treatment interventions, and biologically control those
cancers that we can not eliminate so they become manageable, chronic diseases.
The Abramson
Cancer Center has more nationally recognized research on recurrent breast cancer — in the basic science labs and in the clinic — than any other center in the co
Cancer Center has more nationally recognized
research on recurrent breast
cancer — in the basic science labs and in the clinic — than any other center in the co
cancer —
in the
basic science labs and
in the clinic — than any other center
in the country.
Personalised medicine is becoming relevant
in the treatment of lung
cancer [42, 43] and may have relevance for other lung diseases, like pulmonary fibrosis, asthma and pulmonary hypertension, but disease - related
basic research aimed at searching for biomarkers is needed to achieve personalised and patient - specific treatments for lung diseases.